Electrical impedance characterization of normal and cancerous human hepatic tissue

The four-electrode method was used to measure the ex-vivo complex electrical impedance of tissues from14 hepatic tumors and the surrounding normal liver from 6 patients. Measurements were done in the frequency range of 1 kHz - 400 kHz. It was found that the conductivity of the tumor tissue was much...

Full description

Bibliographic Details
Authors: Laufer, Shlomi, Ivorra Cano, Antoni, 1974-, Reuter, Victor E., Rubinsky, Boris, Solomon, Stephen B.
Format: article
Status:Versión aceptada para publicación
Publication Date:2010
Country:España
Institution:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repository:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10230/26251
Online Access:http://hdl.handle.net/10230/26251
http://dx.doi.org/10.1088/0967-3334/31/7/009
Access Level:Open access
Keyword:Enginyeria biomèdica
Electrofisiologia
Impedància (Electricitat)
Description
Summary:The four-electrode method was used to measure the ex-vivo complex electrical impedance of tissues from14 hepatic tumors and the surrounding normal liver from 6 patients. Measurements were done in the frequency range of 1 kHz - 400 kHz. It was found that the conductivity of the tumor tissue was much higher than that of the normal liver tissue in this frequency range (from 0.14 ±0.06 S m−1 vs. 0.03 ±0.01 S m−1 at 1 kHz to 0.25 ±0.06 S m−1 vs. 0.15 ±0.03 S m−1 at 400 kHz). Cole-Cole models were estimated from the experimental data and the four parameters (ρ0,ρ∞,α,fc) were obtained using a least squares fit algorithm. The Cole-Cole parameters for cancerous and normal liver are (9 ±4 Ω m−1,2.2±0.7 Ω m−1,0.5±0.2,140±103 kHz) and (50±28 Ω m−1,3.2 ±0.6 Ω m−1,0.64±0.04,10±7 kHz), respectively. These data can contribute to developing bioelectric applications for tissue diagnostics, and in tissue treatment planning with electrical fields such as radiofrequency tissue ablation, electrochemotherapy and gene therapy with reversible electroporation, nanoscale pulsing and irreversible electroporation.